South Korea Hemodialysis Market Size, Share, Trends and Forecast by Segment, Modality, End User, and Region, 2026-2034
The South Korea hemodialysis market size reached USD 1,856.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,529.3 Million by 2034, exhibiting a growth rate (CAGR) of 3.39% during 2026-2034. The market is driven by a growing CKD patient base linked to aging and comorbid conditions. Continuous technology upgrades and care-quality innovation are enhancing clinical outcomes and operational efficiency. Strategic public–private healthcare collaboration and sustained government reimbursement further augment the South Korea hemodialysis market share.
SOUTH KOREA HEMODIALYSIS MARKET TRENDS:
Rising Chronic Kidney Disease Prevalence and Aging Population
South Korea is experiencing a steady increase in chronic kidney disease (CKD) prevalence, closely tied to rapid population aging, escalating rates of diabetes, and hypertension. As these conditions advance to end-stage renal disease (ESRD), demand for regular hemodialysis sessions continues to grow. Both hospital-based and freestanding dialysis centers are seeing higher patient volumes, prompting expansion of treatment capacity and service hours. A recent study analyzed 3284 hemodialysis (HD) patients from a nationwide cohort of 5223 individuals in South Korea, with a median age of 58.4 ± 13.6 years and 59.3% male. Over a median follow-up of 66.2 months, the overall mortality rate was 19.3%, highlighting a significant risk of early mortality among these patients. Government health insurance structures offer comprehensive coverage for dialysis, reducing cost barriers and encouraging early initiation of therapy. As more clinics invest in high-efficiency dialysis machines and personalized care programs, patients are benefiting from improved survival rates and quality of life. Chronic disease management initiatives within the national healthcare strategy also emphasize early screening, resulting in more patients being admitted into hemodialysis regimens before complications arise. This demographic and epidemiological shift represents a persistent demand driver, requiring infrastructure expansion, workforce training, and supply-chain readiness. The interplay between an aging cohort, lifestyle-related disease burden, and systemic access to treatment underpins long?term South Korea hemodialysis market growth.
Technological Advancements and Quality-of-Care Enhancements
South Korea’s healthcare providers are continually adopting advanced hemodialysis technologies to optimize outcomes and patient experience. Innovations such as high-flux dialyzers, online hemodiafiltration, and biocompatible membranes are becoming standard in newer clinics. Dialysis machines equipped with digital monitoring, remote data transmission, and AI-assisted analytics help clinicians track complications and intervene early. Portable and home-based dialysis models are also emerging, offering flexibility for patients while reducing costs. Integration with telehealth platforms allows nephrologists to monitor treatment efficacy and adjust prescriptions remotely. Pharmaceutical improvements—like ultrapure water systems and enhanced antithrombogenic coatings—further reduce complications and improve hemodynamic stability during sessions. Clinical training programs ensure that nephrology nurses and technicians are proficient in new systems and patient-centered care. As treatment standards rise, clinics differentiate themselves through precise parameters, comfort features, and better long-term management. These technology and quality upgrades carry both clinical and branding value, reinforcing market expansion and investment in hemodialysis infrastructure across South Korea. As these technological and quality improvements advance patient care, they also play a pivotal role in managing the key factors influencing early mortality, such as comorbidities, dialysis adequacy, and the duration of dialysis. According to a recent 2024 research report, key factors influencing early mortality included comorbidities, especially the modified Charlson Comorbidity Index (mCCI), dialysis adequacy (KT/V), RAAS inhibitor use, and urine output, with shorter dialysis duration (< 14.9 months) and high mCCI scores (7–9) associated with significantly higher mortality risks, with hazard ratios reaching 7.76.
SOUTH KOREA HEMODIALYSIS MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on segment, modality, and end user.
Segment Insights:
Modality Insights:
End User Insights:
Regional Insights:
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea hemodialysis market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea hemodialysis market on the basis of segment?
What is the breakup of the South Korea hemodialysis market on the basis of modality?
What is the breakup of the South Korea hemodialysis market on the basis of end user?
What is the breakup of the South Korea hemodialysis market on the basis of region?
What are the various stages in the value chain of the South Korea hemodialysis market?
What are the key driving factors and challenges in the South Korea hemodialysis?
What is the structure of the South Korea hemodialysis market and who are the key players?
What is the degree of competition in the South Korea hemodialysis market?
SOUTH KOREA HEMODIALYSIS MARKET TRENDS:
Rising Chronic Kidney Disease Prevalence and Aging Population
South Korea is experiencing a steady increase in chronic kidney disease (CKD) prevalence, closely tied to rapid population aging, escalating rates of diabetes, and hypertension. As these conditions advance to end-stage renal disease (ESRD), demand for regular hemodialysis sessions continues to grow. Both hospital-based and freestanding dialysis centers are seeing higher patient volumes, prompting expansion of treatment capacity and service hours. A recent study analyzed 3284 hemodialysis (HD) patients from a nationwide cohort of 5223 individuals in South Korea, with a median age of 58.4 ± 13.6 years and 59.3% male. Over a median follow-up of 66.2 months, the overall mortality rate was 19.3%, highlighting a significant risk of early mortality among these patients. Government health insurance structures offer comprehensive coverage for dialysis, reducing cost barriers and encouraging early initiation of therapy. As more clinics invest in high-efficiency dialysis machines and personalized care programs, patients are benefiting from improved survival rates and quality of life. Chronic disease management initiatives within the national healthcare strategy also emphasize early screening, resulting in more patients being admitted into hemodialysis regimens before complications arise. This demographic and epidemiological shift represents a persistent demand driver, requiring infrastructure expansion, workforce training, and supply-chain readiness. The interplay between an aging cohort, lifestyle-related disease burden, and systemic access to treatment underpins long?term South Korea hemodialysis market growth.
Technological Advancements and Quality-of-Care Enhancements
South Korea’s healthcare providers are continually adopting advanced hemodialysis technologies to optimize outcomes and patient experience. Innovations such as high-flux dialyzers, online hemodiafiltration, and biocompatible membranes are becoming standard in newer clinics. Dialysis machines equipped with digital monitoring, remote data transmission, and AI-assisted analytics help clinicians track complications and intervene early. Portable and home-based dialysis models are also emerging, offering flexibility for patients while reducing costs. Integration with telehealth platforms allows nephrologists to monitor treatment efficacy and adjust prescriptions remotely. Pharmaceutical improvements—like ultrapure water systems and enhanced antithrombogenic coatings—further reduce complications and improve hemodynamic stability during sessions. Clinical training programs ensure that nephrology nurses and technicians are proficient in new systems and patient-centered care. As treatment standards rise, clinics differentiate themselves through precise parameters, comfort features, and better long-term management. These technology and quality upgrades carry both clinical and branding value, reinforcing market expansion and investment in hemodialysis infrastructure across South Korea. As these technological and quality improvements advance patient care, they also play a pivotal role in managing the key factors influencing early mortality, such as comorbidities, dialysis adequacy, and the duration of dialysis. According to a recent 2024 research report, key factors influencing early mortality included comorbidities, especially the modified Charlson Comorbidity Index (mCCI), dialysis adequacy (KT/V), RAAS inhibitor use, and urine output, with shorter dialysis duration (< 14.9 months) and high mCCI scores (7–9) associated with significantly higher mortality risks, with hazard ratios reaching 7.76.
SOUTH KOREA HEMODIALYSIS MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on segment, modality, and end user.
Segment Insights:
- Hemodialysis Product
- Machines
- Dialyzers
- Others
- Hemodialysis Service
- In-center Services
- Home Services
Modality Insights:
- Conventional Hemodialysis
- Short Daily Hemodialysis
- Nocturnal Hemodialysis
End User Insights:
- Hospitals
- Independent Dialysis Centres
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea hemodialysis market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea hemodialysis market on the basis of segment?
What is the breakup of the South Korea hemodialysis market on the basis of modality?
What is the breakup of the South Korea hemodialysis market on the basis of end user?
What is the breakup of the South Korea hemodialysis market on the basis of region?
What are the various stages in the value chain of the South Korea hemodialysis market?
What are the key driving factors and challenges in the South Korea hemodialysis?
What is the structure of the South Korea hemodialysis market and who are the key players?
What is the degree of competition in the South Korea hemodialysis market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1.1 Objectives of the Study
2.1.2 Stakeholders
2.1.3 Data Sources
2.1.3.1 Primary Sources
2.1.3.2 Secondary Sources
2.1.4 Market Estimation
2.1.4.1 Bottom-Up Approach
2.1.4.2 Top-Down Approach
2.1.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA HEMODIALYSIS MARKET - INTRODUCTION
4.1.1 Overview
4.1.2 Market Dynamics
4.1.3 Industry Trends
4.1.4 Competitive Intelligence
5 SOUTH KOREA HEMODIALYSIS MARKET LANDSCAPE
5.1.1 Historical and Current Market Trends (?2020-2025?)
5.1.2 Market Forecast (?2026-2034?)
6 SOUTH KOREA HEMODIALYSIS MARKET - BREAKUP BY SEGMENT
6.1 Hemodialysis Product
6.1.1 Overview
6.1.2 Historical and Current Market Trends (?2020-2025?)
6.1.3 Market Segmentation
6.1.3.1 Machines
6.1.3.2 Dialyzers
6.1.3.3 Others
6.1.4 Market Forecast (?2026-2034?)
6.2 Hemodialysis Service
6.2.1 Overview
6.2.2 Historical and Current Market Trends (?2020-2025?)
6.2.3 Market Segmentation
6.2.3.1 In-center Services
6.2.3.2 Home Services
6.2.4 Market Forecast (?2026-2034?)
7 SOUTH KOREA HEMODIALYSIS MARKET - BREAKUP BY MODALITY
7.1 Conventional Hemodialysis
7.1.1 Overview
7.1.2 Historical and Current Market Trends (?2020-2025?)
7.1.3 Market Forecast (?2026-2034?)
7.2 Short Daily Hemodialysis
7.2.1 Overview
7.2.2 Historical and Current Market Trends (?2020-2025?)
7.2.3 Market Forecast (?2026-2034?)
7.3 Nocturnal Hemodialysis
7.3.1 Overview
7.3.2 Historical and Current Market Trends (?2020-2025?)
7.3.3 Market Forecast (?2026-2034?)
8 SOUTH KOREA HEMODIALYSIS MARKET - BREAKUP BY END USER
8.1 Hospitals
8.1.1 Overview
8.1.2 Historical and Current Market Trends (?2020-2025?)
8.1.3 Market Forecast (?2026-2034?)
8.2 Independent Dialysis Centres
8.2.1 Overview
8.2.2 Historical and Current Market Trends (?2020-2025?)
8.2.3 Market Forecast (?2026-2034?)
8.3 Others
8.3.1 Historical and Current Market Trends (?2020-2025?)
8.3.2 Market Forecast (?2026-2034?)
9 SOUTH KOREA HEMODIALYSIS MARKET – BREAKUP BY REGION
9.1 Seoul Capital Area
9.1.1 Overview
9.1.2 Historical and Current Market Trends (?2020-2025?)
9.1.3 Market Breakup by Segment
9.1.4 Market Breakup by Modality
9.1.5 Market Breakup by End User
9.1.6 Key Players
9.1.7 Market Forecast (?2026-2034?)
9.2 Yeongnam (Southeastern Region)
9.2.1 Overview
9.2.2 Historical and Current Market Trends (?2020-2025?)
9.2.3 Market Breakup by Segment
9.2.4 Market Breakup by Modality
9.2.5 Market Breakup by End User
9.2.6 Key Players
9.2.7 Market Forecast (?2026-2034?)
9.3 Honam (Southwestern Region)
9.3.1 Overview
9.3.2 Historical and Current Market Trends (?2020-2025?)
9.3.3 Market Breakup by Segment
9.3.4 Market Breakup by Modality
9.3.5 Market Breakup by End User
9.3.6 Key Players
9.3.7 Market Forecast (?2026-2034?)
9.4 Hoseo (Central Region)
9.4.1 Overview
9.4.2 Historical and Current Market Trends (?2020-2025?)
9.4.3 Market Breakup by Segment
9.4.4 Market Breakup by Modality
9.4.5 Market Breakup by End User
9.4.6 Key Players
9.4.7 Market Forecast (?2026-2034?)
9.5 Others
9.5.1 Historical and Current Market Trends (?2020-2025?)
9.5.2 Market Forecast (?2026-2034?)
10 SOUTH KOREA HEMODIALYSIS MARKET – COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant
11 PROFILES OF KEY PLAYERS
11.1 Company A
11.1.1 Business Overview
11.1.2 Services Offered
11.1.3 Business Strategies
11.1.4 SWOT Analysis
11.1.5 Major News and Events
11.2 Company B
11.2.1 Business Overview
11.2.2 Services Offered
11.2.3 Business Strategies
11.2.4 SWOT Analysis
11.2.5 Major News and Events
11.3 Company C
11.3.1 Business Overview
11.3.2 Services Offered
11.3.3 Business Strategies
11.3.4 SWOT Analysis
11.3.5 Major News and Events
11.4 Company D
11.4.1 Business Overview
11.4.2 Services Offered
11.4.3 Business Strategies
11.4.4 SWOT Analysis
11.4.5 Major News and Events
11.5 Company E
11.5.1 Business Overview
11.5.2 Services Offered
11.5.3 Business Strategies
11.5.4 SWOT Analysis
11.5.5 Major News and Events
12 SOUTH KOREA HEMODIALYSIS MARKET - INDUSTRY ANALYSIS
12.1 Drivers, Restraints, and Opportunities
12.1.1 Overview
12.1.2 Drivers
12.1.3 Restraints
12.1.4 Opportunities
12.2 Porters Five Forces Analysis
12.2.1 Overview
12.2.2 Bargaining Power of Buyers
12.2.3 Bargaining Power of Suppliers
12.2.4 Degree of Competition
12.2.5 Threat of New Entrants
12.2.6 Threat of Substitutes
12.3 Value Chain Analysis
13 APPENDIX
2 SCOPE AND METHODOLOGY
2.1.1 Objectives of the Study
2.1.2 Stakeholders
2.1.3 Data Sources
2.1.3.1 Primary Sources
2.1.3.2 Secondary Sources
2.1.4 Market Estimation
2.1.4.1 Bottom-Up Approach
2.1.4.2 Top-Down Approach
2.1.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA HEMODIALYSIS MARKET - INTRODUCTION
4.1.1 Overview
4.1.2 Market Dynamics
4.1.3 Industry Trends
4.1.4 Competitive Intelligence
5 SOUTH KOREA HEMODIALYSIS MARKET LANDSCAPE
5.1.1 Historical and Current Market Trends (?2020-2025?)
5.1.2 Market Forecast (?2026-2034?)
6 SOUTH KOREA HEMODIALYSIS MARKET - BREAKUP BY SEGMENT
6.1 Hemodialysis Product
6.1.1 Overview
6.1.2 Historical and Current Market Trends (?2020-2025?)
6.1.3 Market Segmentation
6.1.3.1 Machines
6.1.3.2 Dialyzers
6.1.3.3 Others
6.1.4 Market Forecast (?2026-2034?)
6.2 Hemodialysis Service
6.2.1 Overview
6.2.2 Historical and Current Market Trends (?2020-2025?)
6.2.3 Market Segmentation
6.2.3.1 In-center Services
6.2.3.2 Home Services
6.2.4 Market Forecast (?2026-2034?)
7 SOUTH KOREA HEMODIALYSIS MARKET - BREAKUP BY MODALITY
7.1 Conventional Hemodialysis
7.1.1 Overview
7.1.2 Historical and Current Market Trends (?2020-2025?)
7.1.3 Market Forecast (?2026-2034?)
7.2 Short Daily Hemodialysis
7.2.1 Overview
7.2.2 Historical and Current Market Trends (?2020-2025?)
7.2.3 Market Forecast (?2026-2034?)
7.3 Nocturnal Hemodialysis
7.3.1 Overview
7.3.2 Historical and Current Market Trends (?2020-2025?)
7.3.3 Market Forecast (?2026-2034?)
8 SOUTH KOREA HEMODIALYSIS MARKET - BREAKUP BY END USER
8.1 Hospitals
8.1.1 Overview
8.1.2 Historical and Current Market Trends (?2020-2025?)
8.1.3 Market Forecast (?2026-2034?)
8.2 Independent Dialysis Centres
8.2.1 Overview
8.2.2 Historical and Current Market Trends (?2020-2025?)
8.2.3 Market Forecast (?2026-2034?)
8.3 Others
8.3.1 Historical and Current Market Trends (?2020-2025?)
8.3.2 Market Forecast (?2026-2034?)
9 SOUTH KOREA HEMODIALYSIS MARKET – BREAKUP BY REGION
9.1 Seoul Capital Area
9.1.1 Overview
9.1.2 Historical and Current Market Trends (?2020-2025?)
9.1.3 Market Breakup by Segment
9.1.4 Market Breakup by Modality
9.1.5 Market Breakup by End User
9.1.6 Key Players
9.1.7 Market Forecast (?2026-2034?)
9.2 Yeongnam (Southeastern Region)
9.2.1 Overview
9.2.2 Historical and Current Market Trends (?2020-2025?)
9.2.3 Market Breakup by Segment
9.2.4 Market Breakup by Modality
9.2.5 Market Breakup by End User
9.2.6 Key Players
9.2.7 Market Forecast (?2026-2034?)
9.3 Honam (Southwestern Region)
9.3.1 Overview
9.3.2 Historical and Current Market Trends (?2020-2025?)
9.3.3 Market Breakup by Segment
9.3.4 Market Breakup by Modality
9.3.5 Market Breakup by End User
9.3.6 Key Players
9.3.7 Market Forecast (?2026-2034?)
9.4 Hoseo (Central Region)
9.4.1 Overview
9.4.2 Historical and Current Market Trends (?2020-2025?)
9.4.3 Market Breakup by Segment
9.4.4 Market Breakup by Modality
9.4.5 Market Breakup by End User
9.4.6 Key Players
9.4.7 Market Forecast (?2026-2034?)
9.5 Others
9.5.1 Historical and Current Market Trends (?2020-2025?)
9.5.2 Market Forecast (?2026-2034?)
10 SOUTH KOREA HEMODIALYSIS MARKET – COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant
11 PROFILES OF KEY PLAYERS
11.1 Company A
11.1.1 Business Overview
11.1.2 Services Offered
11.1.3 Business Strategies
11.1.4 SWOT Analysis
11.1.5 Major News and Events
11.2 Company B
11.2.1 Business Overview
11.2.2 Services Offered
11.2.3 Business Strategies
11.2.4 SWOT Analysis
11.2.5 Major News and Events
11.3 Company C
11.3.1 Business Overview
11.3.2 Services Offered
11.3.3 Business Strategies
11.3.4 SWOT Analysis
11.3.5 Major News and Events
11.4 Company D
11.4.1 Business Overview
11.4.2 Services Offered
11.4.3 Business Strategies
11.4.4 SWOT Analysis
11.4.5 Major News and Events
11.5 Company E
11.5.1 Business Overview
11.5.2 Services Offered
11.5.3 Business Strategies
11.5.4 SWOT Analysis
11.5.5 Major News and Events
12 SOUTH KOREA HEMODIALYSIS MARKET - INDUSTRY ANALYSIS
12.1 Drivers, Restraints, and Opportunities
12.1.1 Overview
12.1.2 Drivers
12.1.3 Restraints
12.1.4 Opportunities
12.2 Porters Five Forces Analysis
12.2.1 Overview
12.2.2 Bargaining Power of Buyers
12.2.3 Bargaining Power of Suppliers
12.2.4 Degree of Competition
12.2.5 Threat of New Entrants
12.2.6 Threat of Substitutes
12.3 Value Chain Analysis
13 APPENDIX
